CSIR Indian Institute of Chemical Technology, Hyderabad conducted serological testing of antibodies against SARS-COV 2 in a first phase, with an aim to establish a medical cohort for a long term perspective on Covid 19 and to ascertain the burden of COVID-19 using a serology-based assay that can distinguish SARS-CoV2 from other similar viral infections. This study forms the part of CSIR cohort study initiated by IGIB, New Delhi. Samples were collected from the employees, contract staff and stude

6.6K views · 98 reactions | A constituent of the Council of Scientific and Industrial Research (CSIR), National Aerospace Laboratories (NAL) has developed a Non-Invasive BiPAP Ventilator in a record time of 36 days to treat COVID-19 patients in Bengaluru. | The Times of India | Facebook